CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 80 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q3 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $27,000 | -66.7% | 21,717 | -51.7% | 0.00% | -100.0% |
| Q3 2020 | $81,000 | -83.2% | 44,924 | -21.6% | 0.00% | -88.9% |
| Q2 2020 | $481,000 | +70.0% | 57,300 | +5.9% | 0.01% | +50.0% |
| Q1 2020 | $283,000 | -6.0% | 54,100 | -1.8% | 0.01% | +20.0% |
| Q4 2019 | $301,000 | +13.2% | 55,100 | +0.9% | 0.01% | 0.0% |
| Q3 2019 | $266,000 | -24.0% | 54,600 | +8.0% | 0.01% | -28.6% |
| Q2 2019 | $350,000 | -0.3% | 50,534 | 0.0% | 0.01% | +16.7% |
| Q1 2019 | $351,000 | +64.8% | 50,534 | +38.6% | 0.01% | +50.0% |
| Q4 2018 | $213,000 | +36.5% | 36,460 | +76.5% | 0.00% | +33.3% |
| Q3 2018 | $156,000 | – | 20,660 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $42,335,000 | 24.44% |
| MANGROVE PARTNERS IM, LLC | 552,200 | $4,633,000 | 1.13% |
| ETF MANAGERS GROUP, LLC | 3,707,912 | $31,109,000 | 1.10% |
| Ikarian Capital, LLC | 1,350,000 | $11,327,000 | 0.90% |
| GENERAL AMERICAN INVESTORS CO INC | 712,400 | $5,977,000 | 0.76% |
| AdvisorShares Investments LLC | 189,814 | $1,593,000 | 0.68% |
| Ikarian Capital, LLC | 1,000,000 | $8,390,000 | 0.67% |
| Granite Point Capital Management, L.P. | 1,123,600 | $9,427,000 | 0.48% |
| Carmignac Gestion | 3,773,440 | $31,659,000 | 0.44% |
| Omnia Family Wealth, LLC | 32,356 | $271,467,000 | 0.27% |